Worlds Inc.'s Markman Hearing Rescheduled Due to Crowded

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Worlds Inc.'s Markman Hearing Rescheduled Due to Crowded Court Calendar; Worlds to Proceed With "Uplisting" Process

BOSTON, MA--(Marketwired - Jun 21, 2013) - Worlds Inc. ( OTCBB : WDDD ) has been informed by Judge Denise Casper of the United District Court for the District of Massachusetts that the Markman Hearing in its patent infringement lawsuit against Activision Blizzard, Inc., Blizzard Entertainment, Inc. and Activision Publishing, Inc., which was originally scheduled to be held on June 27, 2013, has been rescheduled to August 22 & 23, 2013. The delay is due to the increased time Judge Casper is being required to devote to the criminal case against James (Whitey) Bulger , an alleged Massachusetts underworld crime boss.

Mr. Thom Kidrin, Worlds' President and CEO, stated, "We are disappointed about the delay, but we understand the Court's constitutional obligation to prioritize criminal matters. The delay will not be wasted, as we intend to continue to proceed with our business plans, which include taking the necessary steps to apply and qualify to be listed on the NASDAQ or another senior exchange."

More information on the lawsuit and Worlds' patents can be found on the Worlds Inc. website at http://www.Worlds.com .

About Worlds Inc.: Worlds Inc. (f.k.a. Worlds.com Inc.) was founded in 1994 and has developed patented 3D technology which offers 3D multi-user environments, known as "virtual worlds," that have interactive Avatars, rich media graphics, text chat, voice-to-voice chat, video and e-commerce. The 3D communities allow visitors to interact with each other, teleport throughout the Worlds environment as well as participate in shared experiences. Besides partnering with existing content providers that have strong brands and an existing following, Worlds also encourages individuals to create their own virtual spaces, communities and unique Avatars with easy-to-use tools.

Forward-Looking Statements This release contains certain forward-looking statements and information relating to Worlds Inc. that are based on the beliefs of Worlds' management, as well as assumptions made based upon information currently available to the Company. Such statements reflect the current views of the Company with respect to future events including estimates and projections about its business based on certain assumptions of its management, including those described in this Release. These statements are not guarantees of future performance and involve risk and uncertainties that are difficult to predict, including, among other factors, changes in demand for the Company's services and products, changes in the economic environment and changes in technology. Additional risk factors are included in the Company's public filings with the SEC. Should one or more of these underlying assumptions prove incorrect, actual results may vary materially from those described herein as "hoped," "anticipated," "believed," "estimated," "should," "preparing," "expected" or words of a similar nature. The Company does not intend to update these forward-looking statements.

Disclaimer with respect to website:

You are advised that the contents of the Company's website are not incorporated by reference into this press release.

CONTACTS: Media Relations: Julie Shepherd Accentuate PR 815 479 1833 Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iBio's Fiscal Year 2024: Innovations and Financial Insights

Updated Category News Views 108

Overview of iBio’s Fiscal Year 2024 Financial Results iBio, Inc. (NYSEA:IBIO), a leader in biopharmaceuticals using AI technology, has recently shared its financial performance for the fiscal year that ended on June 30, 2024. The company is dedicated to developing antibody therapies for complex conditions, utilizing machine learning approaches to enhance their efforts....

Continue Reading
Atossa Therapeutics Ready to Present (Z)-Endoxifen Data Soon

Updated Category News Views 129

Exciting Developments for Atossa Therapeutics at Upcoming Symposium SEATTLE, November 2024 – Atossa Therapeutics, Inc. (NASDAQ: ATOS), a biopharmaceutical company known for its innovative approach in treating breast cancer, is gearing up to share groundbreaking research on (Z)-endoxifen at the upcoming San Antonio Breast Cancer Symposium (SABCS). This symposium is an...

Continue Reading
DraftKings Sportsbook Set to Debut at Live! Casino & Hotel

Updated Category News Views 100

Exciting Announcement for Sports Fans at Live! Casino & Hotel DraftKings is thrilled to announce its role as the official sportsbook for the highly anticipated Live! Casino & Hotel, which boasts a remarkable investment of over $270 million. This venue is set to create waves in the sports entertainment scene. The grand opening is expected, and it promises to be a game...

Continue Reading
Transforming Learning Spaces: A Milestone Celebration Ahead

Updated Category News Views 233

Transforming Learning Spaces with Collaborative Efforts In a remarkable initiative, School Specialty and the College Football Playoff Foundation are making strides in enhancing the educational landscape. Their recent accomplishment includes the makeover of a media center at North Dade Middle School, marking the 100th transformed learning environment as part of the Extra...

Continue Reading
Velvet Taco Innovates Menu with Exciting New Velvet Bowls

Updated Category News Views 481

Velvet Taco Introduces New Velvet Bowls to Excite Diners In an exciting move to shake up its menu, Velvet Taco proudly announces the launch of its latest creation, the Velvet Bowls. This fresh offering arrives after a successful "Weekly Bowl Feature" campaign that highlighted the restaurant's adventurous flavors without the need for tortillas. As a taco restaurant renown...

Continue Reading